Skip to main content
Novartis
language-selector-globe United Kingdom | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe United Kingdom
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the UK 
      • Partnerships 
        • Collaborative working 
          • The Newcastle upon Tyne Hospitals NHS Foundation Trust 
          • Woodlands Family Medical Centre 
          • Mid Ulster Primary Care Heart Failure 
          • Kingswinford and Wordsley Primary Care Network 
        • External funding 
        • Patient group partnership 
      • Sponsorships 
      • Diseases 
      • Strategy 
      • People and culture 
      • Who we are 
      01077_144dpi_16by9_PPT_RGB About
    • Patients and caregivers 
      • External funding 
      • Patient group partnership 
      • Health coaching video series 
      Doctor and Patient Patients and Caregivers
    • Healthcare professionals 
      • For UK healthcare professionals 
      Healthcare Professional Writing Healthcare Professionals
    • ESG 
      • Ethical behaviour 
        • Code of Ethics 
        • Speakup 
      • Ethics, risk and compliance 
      • Access 
      • Environmental sustainability 
      • Global health 
      • Transparency 
        • Healthcare professional payment transparency 
      • Health inequalities 
      Young girl in doctor's office ESG
    • News 
      • Stories 
      • News archive 
      • Novartis UK press office 
      Professional Colleagues Working Together News
    • Careers 
      • Career search 
      • Personal growth 
      • Early talent 
      • How we work 
      • Well-being 
      • Career programmes 
      • Awards and recognition 
      Novartis building Careers
    • Contact 
    Home Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort ascending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort ascending Functional Area Date Posted
TME Profiling Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 07, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Jul 10, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Associate/Manager, MSL (Cardiovascular) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 20, 2024
Medical Field Trainer Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 29, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 05, 2024
Group Manager, MSL Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Sep 05, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Innovative Medicines Research & Development Sep 10, 2024
TA Strategy Lead - GenMed Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 02, 2024
CX strategy Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 04, 2024
TA Strategy Lead, RLT (Prostate Cancer) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 07, 2024
Lead, Integrated Insights & Planning_市場調査 Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 07, 2024
Associate, TA Medical (General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Oct 07, 2024
Head Regulatory Writing Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 07, 2024
Japan Program Head (Neuroscience & GTx) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Japan Program Head (Immunology) Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Manager, TRD Project management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 16, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Associate/Manager, MSL(Oncology) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 22, 2024
Solution Design Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Sep 03, 2024
Investigation Expert Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Associate Clinical Project Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
SSO Feasibility Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 21, 2024
Associate or Manager, PHAD Japan Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Oct 23, 2024
Associate, Country QA Compliance Head Office (Japan) (Pharmaceuticals) Japan Operations Innovative Medicines Quality Oct 22, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Lead/Associate, CX Content Creation Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 20, 2024
Technical System Lead (Qualification) Sasayama Japan Operations Innovative Medicines Technical Operations Jul 31, 2024
MS&T Expansion Lead RLT Sasayama Sasayama Japan Operations Innovative Medicines Technical Operations Jul 31, 2024
Sr. TA Strategy Lead (Renal Therapy Area) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Aug 07, 2024
Project Engineer (Design Phase)_RLT Sasayama Sasayama Japan Operations Innovative Medicines Technical Operations Sep 03, 2024
P&O Business Partner Development & Biomedical Research Japan Head Office (Japan) (Pharmaceuticals) Japan People & Organization Innovative Medicines Human Resources Sep 03, 2024
TA Strategy Lead - Hematology Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Jun 26, 2024
Agile Project Management Lead Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Technology Transformation Jul 01, 2024
Associate, QA Officer Operations Sasayama Japan Operations Innovative Medicines Quality Sep 03, 2024
Associate Director Pipeline Management Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 10, 2024
Japan Program Manager Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 10, 2024
Manager, Reg&Dev Policy Japan​ Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 12, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance Sep 17, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Senior Lead, TA Medical(General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development May 27, 2024
Clinical Biospecimen Senior Scientist Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 03, 2024
Lead, Medical Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 02, 2024
Lead, RWE and Evidence Excellence Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 10, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Jul 18, 2024
QC Analyst Sasayama Japan Operations Innovative Medicines Quality Sep 03, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Oct 18, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • › Next page

Novartis UK

Navigate Novartis
  • Patients and caregivers
  • ESG
  • News
  • Careers
Media Center
  • News archive
  • Stories
Our Portfolio
  • Novartis clinical pipeline
  • Novartis product information
Other Novartis Websites
  • Healthcare Professional portal
  • Novartis global
  • Advanced accelerator applications
  • Novartis biome
  • Novartis clinical trials
Footer Bottom
© 2024 Novartis Pharmaceuticals UK Ltd
  • Privacy policy
  • Terms of use
  • Contact
  • Web accessibility
  • Modern slavery statement
  • Cookie settings
Novartis Site Directory
This site is intended for an audience in the UK